Core Laboratories Inc. $CLB Shares Sold by Goldman Sachs Group Inc.

Goldman Sachs Group Inc. lessened its stake in Core Laboratories Inc. (NYSE:CLB) by 24.0% in the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 193,939 shares of the oil and gas company’s stock after selling 61,343 shares during the quarter. Goldman Sachs Group Inc. owned about 0.41% of Core Laboratories worth $2,907,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently bought and sold shares of CLB. Ariel Investments LLC increased its position in Core Laboratories by 7.4% in the first quarter. Ariel Investments LLC now owns 10,342,025 shares of the oil and gas company’s stock worth $155,027,000 after buying an additional 709,455 shares during the period. Hotchkis & Wiley Capital Management LLC acquired a new stake in Core Laboratories in the first quarter worth $6,008,000. Fred Alger Management LLC increased its position in Core Laboratories by 32.4% in the first quarter. Fred Alger Management LLC now owns 736,853 shares of the oil and gas company’s stock worth $11,045,000 after buying an additional 180,344 shares during the period. Nuveen LLC acquired a new position in shares of Core Laboratories during the first quarter valued at $2,573,000. Finally, Rice Hall James & Associates LLC increased its holdings in shares of Core Laboratories by 71.2% during the first quarter. Rice Hall James & Associates LLC now owns 193,798 shares of the oil and gas company’s stock valued at $2,905,000 after purchasing an additional 80,595 shares during the period. Hedge funds and other institutional investors own 97.81% of the company’s stock.

Analyst Ratings Changes

CLB has been the topic of a number of research analyst reports. Wall Street Zen raised Core Laboratories from a “sell” rating to a “hold” rating in a report on Saturday, July 26th. Zacks Research raised Core Laboratories from a “strong sell” rating to a “hold” rating in a research note on Friday, August 15th. Finally, Stifel Nicolaus decreased their target price on Core Laboratories from $13.00 to $12.00 and set a “hold” rating for the company in a research note on Wednesday, July 16th. Three investment analysts have rated the stock with a Hold rating, According to data from MarketBeat.com, Core Laboratories presently has an average rating of “Hold” and a consensus target price of $12.50.

Core Laboratories Stock Down 5.7%

CLB opened at $11.96 on Friday. Core Laboratories Inc. has a fifty-two week low of $9.72 and a fifty-two week high of $21.83. The business has a 50-day moving average of $11.48 and a 200-day moving average of $12.20. The company has a debt-to-equity ratio of 0.47, a current ratio of 2.27 and a quick ratio of 1.70. The company has a market capitalization of $560.66 million, a PE ratio of 19.29, a price-to-earnings-growth ratio of 3.83 and a beta of 1.46.

Core Laboratories (NYSE:CLB) last issued its quarterly earnings data on Wednesday, July 23rd. The oil and gas company reported $0.19 earnings per share for the quarter, beating analysts’ consensus estimates of $0.18 by $0.01. Core Laboratories had a return on equity of 14.15% and a net margin of 5.73%.The business had revenue of $130.16 million for the quarter, compared to the consensus estimate of $129.19 million. During the same period last year, the business earned $0.22 EPS. The firm’s revenue was down .3% compared to the same quarter last year. Core Laboratories has set its Q3 2025 guidance at 0.180-0.220 EPS. Equities research analysts forecast that Core Laboratories Inc. will post 0.96 EPS for the current fiscal year.

Core Laboratories Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Monday, August 25th. Stockholders of record on Monday, August 4th were issued a dividend of $0.01 per share. This represents a $0.04 annualized dividend and a dividend yield of 0.3%. The ex-dividend date of this dividend was Monday, August 4th. Core Laboratories’s dividend payout ratio (DPR) is presently 6.45%.

About Core Laboratories

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.